Department of Obstetrics and Gynecology, Virginia Tech Carilion Clinic, Roanoke, Virginia.
Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, Virginia.
Am J Perinatol. 2022 Dec;39(16):1735-1741. doi: 10.1055/a-1878-0334. Epub 2022 Jun 16.
This study aimed to assess the positive predictive value (PPV) of a 1-hour, 50-g glucose challenge test (GCT) result ≥200 mg/dL for the diagnosis of gestational diabetes mellitus (GDM) on a 3-hour, 100-g glucose tolerance test (GTT).
Pregnancies between 2008 and 2016 with a GCT result ≥200 mg/dL were identified retrospectively. GCT and GTT dates and results, demographics, and working due date (EDD) were extracted. Gestational age at testing was calculated from test date and EDD. As some clinicians presumptively diagnose GDM in such cases, if a GTT result was not available, clinic notes were reviewed to determine whether a GTT was ordered. Positive predictive values (PPV) were calculated at GCT cut-offs at and beyond 200 mg/dL. Subgroups were compared including early GCT (<16 weeks) versus routine GCT (24-28 weeks), GTT result normal versus GTT diagnostic of GDM, and GTT ordered versus GTT not ordered. Rates of use of medication for glycemic control were assessed among these groups.
Of 236 pregnant women with a GCT result ≥200 mg/dL, 115 (48%) GTT was ordered for 115 (49%), whereas 123 (52%) were managed as presumed GDM. Of 100 (87%) who completed the test, 81 (81%) were diagnosed with GDM with a median intertest interval of 14 days. No statistically significant differences were found between groups stratified by GTT result. Use of rates of metformin, glyburide, and insulin were similar between those diagnosed with GDM by GTT and those diagnosed with GDM by GCT alone.
A GCT result of ≥200 mg/dL has a PPV of 81% for diagnosis of GDM by GTT in a contemporary U.S. population, with a median intertest interval of 14 days between GCT and GTT. However, those diagnosed by GCT alone were as likely as those diagnosed by GTT to require medication for glycemic control, including insulin, suggesting that requiring a GTT may result in underdiagnosis and delayed treatment of GDM.
· A 50-g GCT result of 200 mg/dL or greater has a PPV of 81% for GDM on the 100 g GTT.. · Patients diagnosed with GDM by GCT alone were as likely to require insulin as those diagnosed by GTT.. · 81% of patients diagnosed with GDM on the GTT completed their GTT at least 1 week after the GCT, thus requiring GTT in this population may lead to unnecessary delays in care..
本研究旨在评估 1 小时 50 克葡萄糖挑战试验(GCT)结果≥200mg/dL 对 3 小时 100 克葡萄糖耐量试验(GTT)诊断妊娠期糖尿病(GDM)的阳性预测值(PPV)。
回顾性确定 2008 年至 2016 年间 GCT 结果≥200mg/dL 的妊娠病例。提取 GCT 和 GTT 日期和结果、人口统计学资料和预计分娩日期(EDD)。根据测试日期和 EDD 计算测试时的胎龄。由于一些临床医生在此类情况下推定诊断为 GDM,因此,如果没有 GTT 结果,则会审查临床记录以确定是否已开 GTT。在 GCT 截断值≥200mg/dL 时计算阳性预测值(PPV)。比较了包括早期 GCT(<16 周)与常规 GCT(24-28 周)、GTT 结果正常与 GTT 诊断为 GDM 以及 GTT 开与不开的亚组。评估了这些组中用于血糖控制的药物使用率。
在 236 名 GCT 结果≥200mg/dL 的孕妇中,有 115 名(48%)开了 GTT(49%),而有 123 名(52%)被诊断为疑似 GDM。在 100 名(87%)完成检查的患者中,有 81 名(81%)被诊断为 GDM,两次检查之间的中位间隔时间为 14 天。根据 GTT 结果分层的组之间未发现统计学上的显著差异。通过 GTT 诊断为 GDM 和通过 GCT 单独诊断为 GDM 的患者中,使用二甲双胍、格列本脲和胰岛素的比率相似。
在美国当代人群中,GCT 结果≥200mg/dL 对 GTT 诊断 GDM 的 PPV 为 81%,两次检查之间的中位间隔时间为 14 天。然而,通过 GCT 单独诊断的患者与通过 GTT 诊断的患者一样,可能需要药物控制血糖,包括胰岛素,这表明要求进行 GTT 可能导致 GDM 的诊断不足和治疗延迟。
50g GCT 结果≥200mg/dL 对 100g GTT 诊断 GDM 的 PPV 为 81%。
通过 GCT 单独诊断为 GDM 的患者与通过 GTT 诊断为 GDM 的患者一样,可能需要胰岛素。
通过 GTT 诊断为 GDM 的 81%的患者在 GCT 后至少 1 周完成了 GTT,因此在该人群中要求进行 GTT 可能导致不必要的护理延迟。